The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was well tolerated.

According to the American Academy of Ophthalmology, glaucoma is a group of eye conditions that damage the optic nerve, often ...

Diabetes affects millions worldwide, and while most know about its impact on blood sugar and organ health, vision loss ...

This is a higher dose, longer-acting form of the drug, and it’s used to treat wet AMD, diabetic retinopathy ... treatment with Eylea can cause a long-term increase in the pressure in your eye.

Highlighting the event is the immersive simulation, “Seeing Beyond the Ordinary and Repairing Damages,” led by world-renowned ...

Experiencing fatigue, blurred vision, and unexplained weight loss, a young man sought medical consultation and was informed ...

About AXPAXLI AXPAXLI™ (axitinib intravitreal injection, also known as OTX-TKI) is an investigational, bioresorbable, hydrogel incorporating axitinib, a small molecule, multi-target, tyrosine kinase ...

US-based biotechnology company Ocugen has dosed the first subject in a multicentre Phase I trial of OCU200 for diabetic ...

Ozempic has made headlines as a go-to medication for managing diabetes and aiding weight loss, but its popularity comes with ...

This condition is called diabetic retinopathy. In its early stages ... are at higher risk of developing these conditions, ...

AbbVie (NYSE: ABBV) and REGENXBIO Inc. (Nasdaq: RGNX) today announced updates to the ABBV-RGX-314 clinical program.